Irinores 40 mg Injection
20,97$
16,36$
Irinores 40 mg Injection is a potent topoisomerase inhibitor designed specifically for the management of advanced colorectal cancer. This medication plays a crucial role in disrupting the DNA replication process of cancer cells, ultimately hindering their growth and proliferation. Often prescribed in conjunction with 5-fluorouracil and folinic acid, Irinores is particularly effective for patients who have not undergone prior chemotherapy for their advanced condition. It is essential for patients to discuss their medical history with their healthcare provider, as Irinores may cause serious side effects, including severe allergic reactions and bone marrow suppression. Regular monitoring during treatment is necessary to manage any potential complications. Patients should be aware of the importance of adhering to their treatment regimen to optimize therapeutic outcomes. With its targeted action, Irinores 40 mg Injection represents a significant advancement in the fight against colorectal cancer, offering hope to those battling this challenging disease. Always consult your oncologist for personalized advice and to understand the full scope of this treatment option.
Quantité
Active Pharmaceutical Ingredient
Uses
• Irinores 40 mg injection is primarily used in the treatment of specific types of cancer, particularly colorectal cancer and pancreatic cancer. It works by inhibiting cancer cell growth, thereby helping to manage the disease more effectively. This medication is often part of a broader chemotherapy regimen, tailored to the individual patient’s needs. Healthcare providers determine the best combination of treatments based on various factors.
• In the context of combination therapy, Irinores 40 mg injection enhances the efficacy of other chemotherapy agents. This synergistic effect can lead to improved outcomes for patients undergoing cancer treatment. The injection is administered intravenously, ensuring rapid absorption and action within the body. It is crucial that this medication is given in a controlled clinical environment by trained healthcare professionals.
• The administration of Irinores 40 mg injection is typically reserved for patients with advanced cancer stages, where aggressive treatment is necessary. By disrupting the cancer cell cycle, this medication aims to slow disease progression and manage symptoms. Patients receiving this injection are closely monitored to assess their response to the treatment. This careful oversight helps optimize the therapeutic benefits of Irinores.
• Irinores 40 mg injection is also utilized for patients who have not responded adequately to other treatments. It offers an alternative option for those seeking to control their cancer more effectively. The individualized treatment approach ensures that each patient receives the most appropriate care. This is essential for maximizing the potential benefits of Irinores in their overall treatment plan.
Benefits
Treatment of colon and rectum cancer: Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Irinores 40 mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Uses of Irinores 40 mg Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Constipation
• Fever
• Infection
• Pain
Common Side Effects
• Diarrhea
• Kidney Impairment
• Lung Problems
• Low blood count
How To Use
Benefits of Irinores 40 mg Injection is administered by a qualified doctor or nurse at a hospital or clinical setting. It is given intravenously and is usually given as part of a combination chemotherapy regimen. The specific treatment plan and dosage will depend on the type and stage of the cancer being treated, as well as other individual factors determined by the healthcare provider.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Irinores 40 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Irinores 40 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Irinores 40 mg and report any unusual symptoms or changes in kidney function to their doctor. Irinores 40 mg Injection is not recommended for use in patients on dialysis.
• Breastfeeding: The available data are limited but suggest that Irinores 40 mg Injection and its metabolite are excreted in human milk. Consequently, because of the potential for adverse reactions in nursing infants, breastfeeding should be discontinued for the duration of How Irinores 40 mg Injection works therapy.
• Liver: Benefits of Irinores 40 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Uses of Irinores 40 mg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Irinores 40 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: There are limited data on the use of irinotecan in pregnant women. Benefits of Irinores 40 mg Injection has been shown to be embryotoxic and teratogenic in animals. Therefore, based on results from animal studies and the mechanism of action of Irinores 40 mg, Irinores 40 mg Injection should not be used during pregnancy unless clearly necessary. Women of childbearing potential should not be started on Side effects of Irinores 40 mg Injection until pregnancy is excluded. Pregnancy should be avoided if either partner is receiving Irinores 40 mg Injection.
• Driving: Irinores 40 mg Injection has a moderate influence on the ability to drive and use machines. Patients should be warned about the potential for dizziness or visual disturbances, which may occur within 24 hours following the administration of Side effects of Irinores 40 mg Injection, and advised not to drive or operate machinery if these symptoms occur.